Clinical Cancer Research Abstracts
Careers
Contact | Tell Us About Your Study
Oncology Expertise
Immunotherapy
Operational Expertise
Investigator Relationships
Site Training
Indications
Services
Oncology CRO Services
Study Design
Study Launch
Study Management
Medical Writing
B/DM
Study Rescue
Drug Development Consulting
Access to the U.S. Market
Bioequivalence Design
Experience
Trial Experience
Drug Therapies
Rescue Studies
About
Approach
History
Leadership
Partners
Therapeutic Areas
Oncology
Dental
Nephrology
Medical Device and Diagnostics
Neurology and CNS
News/Blog
Home
Oncology Expertise
Services
Experience
About
Therapeutic Areas
News/Blog
Abstracts
Careers
Contact
News
News
Thought leaders
Phase I
Contract research
Drug development
News
Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024
The 2024 ASCO Annual Meeting presents an unmissable…
Read Article
News
Patient recruitment
FDA’s New Guidance on Diversity in Clinical Trials: New Challenges for Patient Recruitment
The U.S. Food and Drug Administration (FDA) recently…
Read Article
News
The Poster Child of International Clinical Trial Success: Legend Biotech’s Carvykti/Cilta-cel Immunotherapy Achieves FDA Approval
With many in biotech and pharma in China…
Read Article
News
Chinese Clinical Trial Data – Still Relevant to the FDA
For Chinese companies bringing oncology drugs to the…
Read Article
News
FDA Guidance on Conduct of Clinical Trials During COVID-19
These are challenging times, as the world grapples…
Read Article
News
Meet Medelis at the ASH 2019 Annual Meeting
It’s almost December, and that means it’s time…
Read Article
News
Join Medelis at BIO-Europe 2019
BIO-Europe is Europe's largest life science partnering conference…
Read Article
Immunotherapy
News
Common Causes of Delays in Immuno-Oncology Studies
It’s common for “standard” oncology studies to encounter…
Read Article
News
Join Medelis at ASCO 2019
The ASCO 2019 Annual Meeting takes place May…
Read Article
1
2
3
…
5
»
Last »